Emma Morris

Rocky Vista University — United States

Medicine · Health Sciences

48h-index8.0kcitations352works1.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CAR-T cell therapy research(91), Hematopoietic Stem Cell Transplantation(54), Immune Cell Function and Interaction(41), Virus-based gene therapy research(38), Lymphoma Diagnosis and Treatment(35)

Publications350 total

A Meta-Analysis of Self-Determination Interventions for Students With Emotional and Behavioral Disorders
Behavioral Disorders·2025
Prime Editing for p47 <sup>phox</sup> -Deficient Chronic Granulomatous Disease
New England Journal of Medicine·2025· 1 cited
The T385M STAT1 gain-of-function mutation confers the most severe disease outcomes
Frontiers in Immunology·2025Open Access
First in human prime edited autologous hematopoietic stem cell therapy for the treatment of p47phox CGD: Initial results of PRIME-0101
Blood·2025Open Access
Highly efficient collection and manufacture of autologous HSC gene therapy cell product for patients with sickle cell disease using a lentiviral vector containing a shmir targeting BCL11a
Blood·2025
Long-term follow-up of the first in human post-transcriptional genetic silencing of BCL11A in sickle cell disease in a phase 1 pilot and feasibility trial
Blood·2025
From door to ward: optimising admissions for hip fracture patients (Winner of Margaret Dodson award)
Age and Ageing·2025
Patient-reported outcomes in patients with hematologic malignancies treated with CAR T-cell therapy in Europe
Blood Advances·2025Open Access
A parent's perspective on the mentalization-based treatment of a traumatized child
2025
Concluding remarks
2025
Glossary of mentalizing terms
2025
The impact of developmental trauma on children
2025
Mentalization-Based Treatment for Developmental Trauma
2025
Introduction
2025
Novel Clinical Trial Design With Stratum‐Specific Endpoints and Global Test Methods for Rare Diseases With Heterogeneous Clinical Manifestations
Statistics in Medicine·2025
Improved outcome of HSCT in STAT1 gain-of-function disease following JAK inhibition bridging
Journal of Human Immunity·2025· 2 citedOpen Access
Preclinical evaluation of lentiviral gene therapy for adenosine deaminase 2 deficiency (DADA2): engraftment efficiency and biodistribution in humanised NBSGW mice
Gene Therapy·2025Open Access
Allogeneic hematopoietic stem cell transplantation for STAT3 hyper-IgE syndrome: a worldwide study
Blood Advances·2025· 2 citedOpen Access
Haploidentical HSCT: more curative options for patients with CGD
Blood·2025Open Access
Correction to: Pre-Transplant Immune Dysregulation Predicts for Poor Outcome Following Allogeneic Haematopoietic Stem Cell Transplantation in Adolescents and Adults with Inborn Errors of Immunity (IEI)
Journal of Clinical Immunology·2025Open Access
page 1 of 18Next →

Frequent Co-authors

Hans J. Stauss(18), Kirsty Thomson(16), Karl S. Peggs(14), Stephen Mackinnon(14), David C. Linch(10), Ronjon Chakraverty(9), Shao‐An Xue(8), Anthony H. Goldstone(7), Sharyn Thomas(7), Anne Parker(6), Adrian J. Thrasher(6), Daniel P. Hart(6), Panagiotis Kottaridis(6), Angelika Holler(6), Adele K. Fielding(5), Siobhan O. Burns(5), Michela Cesco-Gaspere(5), Constandina Pospori(5), Charles Craddock(4), Gordon Cook(4)